Myeloid sarcoma of the urinary bladder as the presenting feature of secondary acute myeloid leukemia, successfully treated with venetoclax and azacitidine

被引：0
|
作者：
Marko Lucijanic
Cedna Tomasovic-Loncaric
Tajana Stoos-Veic
Tomislav De Both
Barbara Jalsenjak
Rajko Kusec
机构：
[1] University Hospital Dubrava,Hematology Department
[2] University of Zagreb,School of Medicine
[3] University Hospital Dubrava,Pathology and Cytology Department
[4] Catholic University of Croatia,Faculty of Medicine Osijek
[5] Josip Juraj Strossmayer University of Osijek,Urology Department
[6] University Hospital Dubrava,undefined
来源：
Annals of Hematology | 2024年 / 103卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：671 / 672
页数：1
相关论文
共 50 条
  • [41] Orbital myeloid sarcoma secondary to acute myeloblastic leukemia
    Ducloyer, J-B.
    Ducloyer, M.
    Tessoulin, B.
    Lebranchu, P.
    Deltour, J-B.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2020, 43 (01): : E15 - E16
  • [42] Myeloid sarcoma presenting as bilateral acute otitis externa in newly diagnosed acute myeloid leukemia
    Chen, Sarah M.
    Silyerman, Dustin A.
    Jatana, Kris R.
    Chiang, Tendy
    Guinipero, Terri
    Hill, Nina
    Siu, Jason J.
    Reed, Suzanne
    INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY, 2019, 122 : 126 - 129
  • [43] Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients
    Garciaz, Sylvain
    Hospital, Marie-Anne
    Alary, Anne-Sophie
    Saillard, Colombe
    Hicheri, Yosr
    Mohty, Bilal
    Rey, Jerome
    D'Incan, Evelyne
    Charbonnier, Aude
    Villetard, Ferdinand
    Maisano, Valerio
    Lombardi, Laura
    Ittel, Antoine
    Mozziconacci, Marie-Joelle
    Gelsi-Boyer, Veronique
    Vey, Norbert
    CANCERS, 2022, 14 (08)
  • [44] Prediction of Volasertib Sensitivity in Acute Myeloid Leukemia Relapsed or Refractory to Venetoclax Plus Azacitidine
    Patil, Lokesh
    Gu, Christine J.
    Tognon, Cristina
    Long, Nicola
    Johnson, Kara
    Fischer, Melissa A.
    Ball, Somedeb
    Savona, Michael R.
    Leonardi, Chris
    Wagner, Joseph
    Michelson, Glenn
    Lacher, Markus D.
    BLOOD, 2024, 144 : 5818 - 5819
  • [45] Venetoclax Resistance in Acute Myeloid Leukemia
    Garciaz, Sylvain
    Hospital, Marie-Anne
    Collette, Yves
    Vey, Norbert
    CANCERS, 2024, 16 (06)
  • [46] Venetoclax in adult acute myeloid leukemia
    Hu, Mengci
    Li, Wenzhe
    Zhang, Youshan
    Liang, Caixia
    Tan, Jie
    Wang, Ya
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
  • [47] A Phase II Study of Azacitidine and Venetoclax as Maintenance Therapy in Patients With Acute Myeloid Leukemia
    Bazinet, Alexandre
    Kantarjian, Hagop
    Borthakur, Gautam
    Yilmaz, Musa
    Bose, Prithviraj
    Jabbour, Elias
    Alvarado, Yesid
    Chien, Kelly
    Pemmaraju, Naveen
    Takahashi, Koichi
    Short, Nicholas
    Daver, Naval
    Issa, Ghayas
    Jain, Nitin
    Bull-Linderman, Debra
    DiNardo, Courtney
    Montalban-Bravo, Guillermo
    Garcia-Manero, Guillermo
    Sasaki, Koji
    Ravandi, Farhad
    Kadia, Tapan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S239 - S240
  • [48] Real-world experience of venetoclax with azacitidine for untreated patients with acute myeloid leukemia
    Winters, Amanda C.
    Gutman, Jonathan A.
    Purev, Enkhtsetseg
    Nakic, Molly
    Tobin, Jennifer
    Chase, Stephanie
    Kaiser, Jeff
    Lyle, Lindsey
    Boggs, Chelsey
    Halsema, Keri
    Schowinsky, Jeffrey T.
    Rosser, Julie
    Ewalt, Mark D.
    Siegele, Bradford
    Rana, Vishal
    Schuster, Steven
    Abbott, Diana
    Stevens, Brett M.
    Jordan, Craig T.
    Smith, Clayton
    Pollyea, Daniel A.
    BLOOD ADVANCES, 2019, 3 (20) : 2911 - 2919
  • [49] Venetoclax and azacitidine compared with induction chemotherapy for newly diagnosed patients with acute myeloid leukemia
    Cherry, Evan M.
    Abbott, Diana
    Amaya, Maria
    McMahon, Christine
    Schwartz, Marc
    Rosser, Julie
    Sato, Audrey
    Schowinsky, Jeffrey
    Inguva, Anagha
    Minhajuddin, Mohd
    Pei, Shanshan
    Stevens, Brett
    Winters, Amanda
    Jordan, Craig T.
    Smith, Clayton
    Gutman, Jonathan A.
    Pollyea, Daniel A.
    BLOOD ADVANCES, 2021, 5 (24) : 5565 - 5573
  • [50] Venetoclax and Azacitidine in Chinese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy
    Leiming Xia
    Wanlu Tian
    Yiming Zhao
    Lingling Jiang
    Wei Qian
    Lei Jiang
    Ling Ge
    Jianjun Li
    Fengbo Jin
    Mingzhen Yang
    Signal Transduction and Targeted Therapy, 8
12345